Clinical Trial Update: Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC [Phase 2]

View source ↗

Summary

Phase 2 study evaluating chidamide plus chemotherapy as neoadjuvant treatment for HR+/ HER2- breast cancer; status and results not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Shengjing Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN